BrainStorm Cell Therapeutics
BCLI
#10709
Rank
HK$84.78 M
Marketcap
HK$7.68
Share price
6.52%
Change (1 day)
46.10%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of March 2026 : HK$11.66 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is HK$11.66 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$1.61 M-71.05%
2024-12-31HK$5.58 M-43.87%
2023-12-31HK$9.95 M-68.86%
2022-12-31HK$31.97 M-19.25%
2021-12-31HK$39.6 M-29.21%
2020-12-31HK$55.94 M203.62%
2019-12-31HK$18.42 M
2018-12-31N/A
2010-12-31HK$1.06 M-62.84%
2009-12-31HK$2.86 M-16.2%
2008-12-31HK$3.42 M-71.51%
2007-12-31HK$12.01 M37.2%
2006-12-31HK$8.75 M
2006-03-31HK$3.86 M
2004-03-31HK$0.24 M47.42%
2003-03-31HK$0.16 M107.37%
2002-03-31HK$0.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
HK$51.44 B 440,887.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$173.85 B 1,490,088.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
HK$0.88 B 7,526.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$10.10 B 86,507.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.32 B 2,660.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA